Home » Topics » BioWorld Science

BioWorld Science
RSS

Nanogen granted U.S. patent on APEX technology

May 2, 1997

Oncor licenses new genetic biomarker for prostate cancer

May 2, 1997

Sheffield Medical Technologies acquires Camelot Pharmacal

May 2, 1997

Somatogen initiates phase II Optro trial for new indication

May 2, 1997

Cortech and Ono amend research agreement

May 2, 1997

Neurobiological Technologies initiates second phase II memantine trial

May 2, 1997

Agouron acquires Alanex

May 2, 1997

Zeneca and the University of Oxford enter collaboration for genetic research into heart disease

May 2, 1997

Oxford BioMedica acquires anticancer macrophage technology

May 2, 1997

FDA clears Hemagen's RF test

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...